Gynecology and reproductive endocrinology最新文献

筛选
英文 中文
Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service. 在妇科肿瘤服务中实施限制性输血方案。
Gynecology and reproductive endocrinology Pub Date : 2019-01-01 DOI: 10.35841/2591-7994.3.1-5
Jaron Mark, Sarah Lynam, Kayla Morrell, Kevin Eng, Kristen Starbuck, J Brian Szender, Emese Zsiros, Peter J Frederick
{"title":"Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service.","authors":"Jaron Mark, Sarah Lynam, Kayla Morrell, Kevin Eng, Kristen Starbuck, J Brian Szender, Emese Zsiros, Peter J Frederick","doi":"10.35841/2591-7994.3.1-5","DOIUrl":"10.35841/2591-7994.3.1-5","url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study was to evaluate the impact of a restrictive blood transfusion protocol in a postoperative gynecologic oncology population. The primary objective was the rate of blood transfusions after surgery before and after implementation of a restrictive transfusion protocol (from July 1<sup>st</sup> 2011 to December 30<sup>th</sup> 2016). Secondary outcomes were patient morbidity and included rates of surgical site infection, pneumonia, sepsis, unplanned intubation, prolonged ventilator use, renal insufficiency, acute renal failure, urinary tract infection, cerebral vascular accident, cardiac complications, venous thromboembolism, and death within 30 days of surgery, readmissions and length of stay.</p><p><strong>Methods: </strong>A restrictive blood transfusion protocol was implemented by the gynecologic oncology service at a National Comprehensive Cancer Network designated Comprehensive Cancer Center on January 1<sup>st</sup>, 2014. The restrictive protocol required that no patient receive a blood transfusion for hemoglobin greater than 7.0 g/dL (or hematocrit greater than 21.0%) and that all red blood cells were administered in one unit increments followed by re-evaluation of blood parameters. Exceptions to this protocol were postoperative symptomatic anemia, intraoperative or day of surgery transfusion, active bleeding, postoperative severe sepsis, postoperative active coronary ischemia, and postoperative transfusion after 1.5 liter or greater blood loss.</p><p><strong>Results: </strong>1482 patients were identified for this study (755 in the pre-protocol group and 727 in the post-protocol group). Patients treated under the restrictive protocol had decreased rates of red blood cell transfusion (11.0% <i>vs</i> 5.9% p<0.001), superficial surgical site infection (7.7% <i>vs</i> 4.1% p=0.005), deep surgical site infection (2.3% <i>vs</i> 0.7% p=0.02), and median length of stay (3.0 days <i>vs</i> 2.0 days p<0.001).</p><p><strong>Conclusions: </strong>A restrictive blood transfusion protocol is associated with reductions in the rates of blood transfusions and postoperative morbidity with a 46.8% reduction in superficial surgical site infection and a 69.6% decrease in deep surgical site infection in the gynecologic oncology patient population.</p>","PeriodicalId":93002,"journal":{"name":"Gynecology and reproductive endocrinology","volume":"3 1","pages":"1-5"},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299237/pdf/nihms-1029689.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38059606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of follicular fluid concentrations of anti-mullerian hormone, bone morphogenetic protein 15 and transforming growth factor ß1 between modified natural and stimulated in-vitro fertilization cycles. 改良自然和刺激体外受精周期卵泡液中抗苗勒管激素、骨形态发生蛋白15和转化生长因子ß1浓度的比较。
Gynecology and reproductive endocrinology Pub Date : 2019-01-01 DOI: 10.35841/2591-7994.3.12-13
T. Burnik Papler
{"title":"Comparison of follicular fluid concentrations of anti-mullerian hormone, bone morphogenetic protein 15 and transforming growth factor ß1 between modified natural and stimulated in-vitro fertilization cycles.","authors":"T. Burnik Papler","doi":"10.35841/2591-7994.3.12-13","DOIUrl":"https://doi.org/10.35841/2591-7994.3.12-13","url":null,"abstract":"","PeriodicalId":93002,"journal":{"name":"Gynecology and reproductive endocrinology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70031376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信